AIDS — An African Disease?

  • Kevin M. De Cock
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 187)


Compelling evidence exists incriminating the lymphotropic retroviruses LAV1 (lymphadenopathy associated virus) and HTLV-III2 (human T lymphotropic virus-III) as the causative agents of the acquired immunodeficiency syndrome (AIDS). Understandably, research has concentrated on elucidating the cause of AIDS, studying its immunology and clinical features, and establishing its epidemiology. There are a number of broad questions that still deserve consideration: (1) Is this a new disease? (2) Why has it appeared now? (3) Why is it specifically associated with Kaposi’s sarcoma (KS)? (4) What is the association with Haiti? (5) Why does it affect homosexuals, drug users and haemophiliacs? (6) What is the significance of the increasing number of black African cases?


Acquire Immune Deficiency Syndrome Acquire Immunodeficiency Syndrome Acquire Immune Deficiency Syndrome Patient Lassa Fever Cloacogenic Carcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Barre-Sinoussi F, Chermann JC, Rey F, et al. Isolation of a T lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983, 220: 868–870.PubMedCrossRefGoogle Scholar
  2. 2.
    Gallo RC, Salahuddin SZ, Popoic M, et al. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 1984; 224: 500–502.PubMedCrossRefGoogle Scholar
  3. 3.
    De Cock KM. AIDS: An old disease from Africa? Br Med J 1984, 289: 306–308.Google Scholar
  4. 4.
    Frame JD, Baldwin JM, Gocke DJ, Troup JM. Lassa fever, a new virus disease of man from West Africa. I. Clinical description and pathological findings. Am J Trop Med Hyg 1970, 19: 670–676.PubMedGoogle Scholar
  5. 5.
    Martini GA, Siegart R, Marburg virus disease. Berlin: Springer Verlag 1971.Google Scholar
  6. 6.
    Gear JSS, Cassel GA, Gear AJ, et al. Outbreak of Marburg virus disease in Johannesburg. Br Med J 1975, 4: 489–493.PubMedCrossRefGoogle Scholar
  7. 7.
    Smith DH, Johnson BK, Isaacson M, et al. Marburg virus disease in Kenya. Lancet 1982, 1: 816–820.PubMedCrossRefGoogle Scholar
  8. 8.
    WHO International Study Team. Ebola haemorrhagic fever in Sudan, 1976. Bull WHO 1978, 56: 247–270.Google Scholar
  9. 9.
    International Commission. Ebola haemorrhagic fever in Zaire, 1976. Bull WHO 1978, 56: 271–293.Google Scholar
  10. 10.
    Oettle AS. Geographical and racial differences in the frequency of Kaposi’s sarcoma as evidence of environmental or genetic causes. Acta Un Int Cancer 1962, 18: 330–363.Google Scholar
  11. 11.
    Hütt MSR. The epidemiology of Kaposi’s sarcoma. Antibiot Chemother 1981, 29: 3–8.PubMedGoogle Scholar
  12. 12.
    Templeton AC. Kaposi’s sarcoma. IN: Sommers SC, Rosen PP, Pathology Annual, Appleton-Century-Crofts, New York, 1981, 16, part 2, 315–336.Google Scholar
  13. 13.
    Master SP, Taylor JF, Kyalwazi SK, Ziegler JL. Immunological studies in Kaposi’s sarcoma in Uganda. Br Med J 1970, 600–602.Google Scholar
  14. 14.
    Taylor JF. Lymphocyte transformation in Kaposi’s sarcoma. Lancet, 1973, 1: 883–884.PubMedCrossRefGoogle Scholar
  15. 15.
    Taylor JF, Ziegler JL. Delayed cutaneous hypersensi- tivity reactions in patients with Kaposi’s sarcoma. Br J Cancer 1974, 30: 312–318.PubMedCrossRefGoogle Scholar
  16. 16.
    Downing RG, Eglin RP, Bayley AC. African Kaposi’s sarcoma and AIDS. Lancet 1984, 1: 478–480.PubMedCrossRefGoogle Scholar
  17. 17.
    Anonymous. Update. Acquired immunodeficiency syndrome (AIDS) - United States. MMWR 1984, 33: 337–339.Google Scholar
  18. 18.
    Weber J. Is AIDS an epidemic form of African Kaposi’s sarcoma? Discussion paper. J Roy Soc Med 1984, 77: 572–576.PubMedGoogle Scholar
  19. 19.
    Ziegler JL, Drew WL, Miner RC, et al. Outbreak of Burkitt’s-like lymphoma in homosexual men. Lancet 1982, 2: 631–633.PubMedCrossRefGoogle Scholar
  20. 20.
    Ziegler JL, Beckstead JA, Volberding PA, et al. Non-Hodgkins’ lymphoma in 90 homosexual men. N Engl J Med 1984, 311: 565–570.PubMedCrossRefGoogle Scholar
  21. 21.
    Burkitt DP. Geographical distribution. In: Burkitt DP, Wright DH eds. Burkitt’s Lymphoma. Edingburgh: Livingstone, 1970, 186–197.Google Scholar
  22. 22.
    Cook PJ, Burkitt DP. Cancer in Africa. Br Med Bull 1971, 27: 14–20.PubMedGoogle Scholar
  23. 23.
    Kungu A, Gatei DG. Kaposi’s sarcoma in Kenya. Antibiot Chemother 1981, 29: 38–55.PubMedGoogle Scholar
  24. 24.
    Pape JW, Liautaud B, Thomas F, et al. Characteristics of the acquired immunodeficiency syndrome (AIDS) in Haiti. N Engl J Med. 1983, 309: 945–950.PubMedCrossRefGoogle Scholar
  25. 25.
    Centers for Disease Control Task Force on Kaposi’s Sarcoma and Opportunistic Infections, Epidemiologic aspects of the current outbreaks of Kaposi’s sarcoma and opportunistic infections. H Engl J Med 1982, 306: 248–252.Google Scholar
  26. 26.
    Anonymous. Update: Acquired Immunodeficiency Syndrome (AIDS) - United States. MMWR 1974, 33: 661–663.Google Scholar
  27. 27.
    Bygbjerg IC. AIDS in a Danish surgeon (Zaire, 1976). Lancet 1983, 1: 925.PubMedCrossRefGoogle Scholar
  28. 28.
    Vandepitte J, Verwilghen R, Zachee P. AIDS and cryptococcosis (Zaire 1977). Lancet 1983, 1: 925–926.PubMedCrossRefGoogle Scholar
  29. 29.
    Clumeck H, Sonnet J, Taelman H, et al. Acquired immunodeficiency syndrome in African patients. N Engl J Med 1984, 310: 492–497.PubMedCrossRefGoogle Scholar
  30. 30.
    Anonymous. The epidemiology of AIDS in Europe. Eur J Cancer Clin Oncol 1984, 20: 157–164.CrossRefGoogle Scholar
  31. 31.
    Van, de Perre P, Rouvroy D, Lepage P, Acquired immunodeficiency syndrome in Rwanda. Lancet 1984, 2: 62–65.Google Scholar
  32. 32.
    Piot P, Quinn TC, Taelman H, et al. Acquired immuno- deficiency syndrome in a heterosexual population in Zaire. Lancet 1984, 2: 65–69.PubMedCrossRefGoogle Scholar
  33. 33.
    Lamey B, Melameka N. Aspects cliniques et epidemiolo- giques de la cryptococcose a Kinshasa: a propos de 15 cas personnels. Med Trop 1982, 42: 507–511.Google Scholar
  34. 34.
    Bayley AC. Aggressive Kaposi’s sarcoma in Zambia, 1983. Lancet 1984, 1: 1318–1320.PubMedCrossRefGoogle Scholar
  35. 35.
    Clumeck N, Mascart-Lemone F, De Maubeuge J, Brenez D, Marcelis L. Acquired immune deficiency syndrome in black Africans. Lancet 1983» 1: 642.Google Scholar
  36. 36.
    Offenstadt G, Pinta P, Hericord P, et al. Multiple opportunistic infection due to AIDS in a previously healthy black woman from Zaire. N Engl J Med 1983, 308: 775.PubMedGoogle Scholar
  37. 37.
    Brunet JB, Bouvet E, Leibowitch J, et al. Acquired immunodeficiency syndrome in France. Lancet 1983, 1: 700–701.PubMedCrossRefGoogle Scholar
  38. 38.
    Vittecoq D, Modai J. AIDS in a Black Malian. Lancet 1983, 2:1023-Google Scholar
  39. 39.
    Edwards D, Harper PG, Pain AK, et al. Kaposi’s sarcoma associated with AIDS in a woman from Uganda. Lancet 1984, 1: 631–632.PubMedCrossRefGoogle Scholar
  40. 40.
    Ellrodt A, Barre-Sinoussi F, Le Bras PL, et al. Isolation of human T lymphotropic retrovirus (LAV) from Zairean married couple, one with AIDS, one with prodromes. Lancet 1984, 1: 1383–1385.PubMedCrossRefGoogle Scholar
  41. 41.
    Raine AEG, Ilgren EB, Kurtz JB, Ledingham JGG, Waddell JA. HTLV-III infection and AIDS in a Zambian nurse resident in Britain. Lancet 1984, 2: 985.PubMedCrossRefGoogle Scholar
  42. 42.
    Anonymous. Clinical features of AIDS in Europe. Eur J Cancer Clin Oncol 1984, 20: 165–167.CrossRefGoogle Scholar
  43. 43.
    Saxinger W, Blattner WA, Levine PH, et al. Human T cell leukaemia virus (HTLV-I) antibodies in Africa. Science 1984, 225: 1473–1476.PubMedCrossRefGoogle Scholar
  44. 44.
    Biggar RJ, Saxinger C, Gardiner C, et al. Type-I HTLV antibody in urban and rural Ghana, West Africa. Int J Cancer 1984, 34: 215–219.PubMedCrossRefGoogle Scholar
  45. 45.
    Fleming AF, Yamamoto N, Bhusnurmath SR, et al. Antibodies to ATLV (HTLV) in Nigerian blood donors and patients wth chronic lymphatic leukaemia or lymphoma. Lancet 1983, 2: 334–335.PubMedCrossRefGoogle Scholar
  46. 46.
    Williams CKO, Alabi GO, Junaid TA, et al. Human T cell leukaemia virus associated lymphoproliferative disease: report of two cases in Nigeria. Br Med J 1984, 288: 1495–1496.CrossRefGoogle Scholar
  47. 47.
    Stewart JSW, Matutes E, Lampert IA, Goolden AWS, Catovsky D. HTLV-I positive T cell lymphoma/leukaemia in an African resident in UK. Lancet 1984, 2: 984–985.PubMedCrossRefGoogle Scholar
  48. 48.
    Gallo RC, Sliski A, Wong-Staal F. Origin of human T-cell leukaemia-lymphoma virus. Lancet 1983, 2: 962–963.PubMedCrossRefGoogle Scholar
  49. 49.
    Broder S, Gallo RC. A pathogenic retrovirus (HTLV-III) linked to AIDS. N Engl J Med 1984, 311: 1292–1297.PubMedCrossRefGoogle Scholar
  50. 50.
    Feremans W, Menu R, Dustin P, Clumeck N, Marcelis L, Hupin J. Virus-like particles in lymphocytes of seven cases of AIDS in Black Africans. Lancet 1984, 2: 52–53.Google Scholar
  51. 51.
    Biggar RJf Melbye M, Kestems L, Kaposi’s sarcoma in Zaire is not associated with HTLV-III infection. N Engl J Med 1984, 311: 1051–1052.Google Scholar
  52. 52.
    Brun-Vezinet F, Rouzioux C, Montagnier L, et al. Prevalence of antibodies to lymphadenopathy-associated retrovirus in African patients with AIDS. Science 1984, 226: 453–456.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1985

Authors and Affiliations

  • Kevin M. De Cock
    • 1
  1. 1.USC Liver UnitRancho Los Amigos HospitalDowneyUSA

Personalised recommendations